American Academy of Ophthalmology Web Site: www.aao.org
Products & Services
(PDF 102 KB)
New Slit Lamp
Topcon Medical Systems has announced the release of its SL-3G Slit Lamp.
It features a stereoscopic converging microscope and optics that are designed to provide the practitioner with fatigue-free viewing and clear images. Magnifications can be changed between 1x and 1.6x. A 6-V, 20-W halogen bulb is intended to provide consistent illumination that resembles natural daylight to facilitate extended observation. The resulting color rendition allows for narrower slit apertures for finer, detailed observation.
Additional features include an omnidirectional control lever, a 20-degree slit beam inclination intended for added versatility in gonioscopy and fundus observation, four built-in filters to facilitate special exams, continuous adjustment of slit aperture and an angular measurement scale for simplifying the fitting of astigmatic contact lenses.
The SL-3G is available with a variety of optional accessories and can be integrated with the LC-300G and other laser photocoagulators that accept various delivery systems.
Topcon Medical Systems
New Presbyopia-Correcting IOLs
Alcon has announced that the FDA approved its AcrySof IQ ReStor +3.0 D IOL for cataract surgery in patients with presbyopia.
According to the company, U.S. clinical trials included a three-month follow-up exam of near, intermediate and distance visual acuities. The percentage of patients who achieved 20/20 or better at all three distances with the IOL was nearly fourfold the rate of patients who received the control lens, the AcrySof IQ ReStor +4.0 D IOL. In addition, the company reports that clinical studies showed a high rate of patient satisfaction with over 95 percent of patients stating that they would have the lens implanted again.
Allergan has announced that the FDA approved its Latisse (bimatoprost ophthalmic solution) 0.03 percent for hypotrichosis of the eyelashes.
Latisse is the first science-based treatment approved by the FDA to enhance eyelash prominence as measured by increased length, thickness and darkness of lashes. The solution is used once daily by applying the treatment to the base of the upper eyelashes with a sterile single-use-per-eye disposable applicator.
The company reports that in approximately eight weeks, users will start to see results, and by 16 weeks, results will be significant.
The effects of Latisse require ongoing treatment in order to be maintained. If treatment is discontinued, eyelashes will gradually return over a period of weeks or months to their state prior to treatment.
Capsulorhexis ForcepsBausch & Lomb Storz Instruments has introduced the Utrata Micro Capsulorhexis Forceps (E2002 M).
The fine-angled tips of this instrument are ideal for grasping the capsule when performing 1.8-mm procedures during microincisional cataract surgery. The 12-mm shafts are angled and include an iris stop to allow ease of movement in the anterior chamber. This stainless-steel instrument has a flat handle with a satin finish.
Bausch & Lomb Storz Instruments
Orbital Tissue Expander
FCI Ophthalmics announces the Orbital Tissue Expander, an inflatable device for treatment of congenital anophthalmia, congenital microphthalmia and acquired anophthalmia.
The device is designed to help achieve facial symmetry through facilitating the normal growth of orbital soft tissues and bone. It consists of a flexible balloon/expander held in place by a titanium fixation plate that is anchored to the lateral orbital rim by screws. A slotted arm attached to the fixation plate allows one to center the device in the expanding socket as the orbit grows. Sterile saline solution can be injected as needed into the balloon through a self-sealing injection port.